文献速递肝病消化道肿瘤与早癌

中国大型队列中非酒精性脂肪性肝病与癌症的关联

Associations Between Nonalcoholic Fatty Liver Disease and Cancers in a Large Cohort in China.
PubMed 文献 · Clin Gastroenterol Hepatol · 2020-05-11

基于开滦队列54,187名中国成年男性的前瞻性研究显示,非酒精性脂肪性肝病(NAFLD)患病率为32.3%,且与所有癌症、甲状腺癌和肺癌风险升高相关;在NAFLD男性中,ALT≥80 U/L与肝细胞癌风险升高相关。

要点

  • NAFLD男性所有癌症风险升高(HR 1.22),甲状腺癌(HR 2.79)和肺癌(HR 1.23)风险亦升高。
  • NAFLD男性中ALT≥80 U/L与肝细胞癌风险升高相关(HR 8.08)。
  • 吸烟者中NAFLD增加结直肠癌和肺癌风险,非糖尿病男性中增加肾癌风险。

核心结论

  • 中国男性NAFLD患者肝外癌症风险升高,包括甲状腺癌和肺癌。
  • NAFLD男性中较高ALT水平与甲状腺癌和肝细胞癌风险升高相关。
  • NAFLD仅在吸烟者中增加结直肠癌和肺癌风险,仅在非糖尿病男性中增加肾癌风险。

研究设计与样本

  • 开滦队列为社区为基础的前瞻性队列,纳入54,187名中国成年男性,数据收集于2006年6月至2007年10月。
  • NAFLD通过超声诊断,排除其他慢性肝病原因;采用Fine和Gray竞争风险回归模型评估NAFLD(无肝硬化)与癌症的关联。

主要发现

  • NAFLD患病率为32.3%。

临床怎么用

  • 对NAFLD男性患者应关注肝外癌症风险,尤其是甲状腺癌和肺癌。
  • NAFLD男性中ALT≥80 U/L提示肝细胞癌风险显著升高,需加强监测。
  • 吸烟的NAFLD男性应重视结直肠癌和肺癌筛查。
  • 非糖尿病的NAFLD男性需注意肾癌风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: The relationship between nonalcoholic fatty liver disease (NAFLD) and cancer, especially extrahepatic cancers, has not been fully clarified. We analyzed data from a large prospective cohort study to determine the relationship between NAFLD and development of cancers in men. METHODS: We collected data from the Kailuan cohort, a community-based cohort of 54,187 adult men in China, from June 2006 through October 2007. NAFLD was diagnosed by ultrasonography after excluding other causes related to chronic liver disease. Fine and Gray competing risk regression model was used to evaluate associations between NAFLD (without cirrhosis) and cancers. RESULTS: The prevalence of NAFLD was 32.3%. NAFLD was associated with increased risk of all cancers (hazard ratio [HR], 1.22; 95% CI, 1.10-1.36; P = .0001), thyroid cancer (HR, 2.79; 95% CI, 1.25-6.21; P = .01), and lung cancer (HR, 1.23; 95% CI, 1.02-1.49; P = .03). The association between NAFLD and risk of thyroid cancer increased with level of alanine aminotransferase (ALT). In men with NAFLD, level of ALT 80 U/L or more was associated with hepatocellular carcinoma (HR, 8.08; 95% CI, 2.46-26.56; P = .0006). NAFLD increased risk of colorectal cancer (HR, 1.96; 95% CI, 1.17-3.27) and lung cancer (HR, 1.38; 95% CI, 1.03-1.84) only in smokers. An association between NAFLD and kidney cancer (HR, 1.57; 95% CI, 1.03-2.40) was only observed in men without diabetes. CONCLUSIONS: A cohort study from China found that men with NAFLD have a higher risk of extrahepatic cancers, including thyroid and lung cancer. In men with NAFLD, higher levels of ALT were associated with higher risk of thyroid and hepatocellular cancer. NAFLD increased risk of colorectal and lung cancer only in smokers, and increased risk of kidney cancer in men without diabetes.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Wang Z, Zhao X, Chen S, et al. Associations Between Nonalcoholic Fatty Liver Disease and Cancers in a Large Cohort in China. Clin Gastroenterol Hepatol. 2020. PMID: 32407969. doi:10.1016/j.cgh.2020.05.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。